Figure 1From: Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trialsThe flowchart. RT: radiotherapy; RCTs: randomized controlled trials, EBCT: Early Breast conserving therapy.Back to article page